Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy
出版年份 2022 全文链接
标题
Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy
作者
关键词
-
出版物
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-05-24
DOI
10.1007/s00259-022-05842-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Imaging of Fibroblast Activation Protein in Cancer Xenografts Using Novel (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine-Based Small Molecules
- (2021) Stephanie L. Slania et al. JOURNAL OF MEDICINAL CHEMISTRY
- 68Ga-DOTA-FAPI-04 PET/MR in the evaluation of gastric carcinomas: comparison with 18F-FDG PET/CT
- (2021) Chunxia Qin et al. JOURNAL OF NUCLEAR MEDICINE
- A Trifunctional Theranostic Ligand Targeting Fibroblast Activation Protein-α (FAPα)
- (2021) James M. Kelly et al. MOLECULAR IMAGING AND BIOLOGY
- An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications
- (2021) Jacopo Millul et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Indications of Peptide Receptor Radionuclide Therapy (PRRT) in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors: An Updated Review
- (2021) Baptiste Camus et al. Journal of Clinical Medicine
- State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis
- (2021) Martina Sollini et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CT
- (2021) Stefan A. Koerber et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Feasibility, Biodistribution and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy (PTRT) of Diverse Adenocarcinomas using 177Lu-FAP-2286: First-in-Human Results
- (2021) Richard P Baum et al. JOURNAL OF NUCLEAR MEDICINE
- Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
- (2021) Oliver Sartor et al. NEW ENGLAND JOURNAL OF MEDICINE
- 68Ga-FAPI-04 Versus 18F-FDG PET/CT in the Detection of Hepatocellular Carcinoma
- (2021) Hao Wang et al. Frontiers in Oncology
- Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga]Ga-OncoFAP-DOTAGA
- (2021) P. Backhaus et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Imaging DNA Damage Repair in vivo Following 177Lu-DOTATATE Therapy
- (2020) Edward O'Neill et al. JOURNAL OF NUCLEAR MEDICINE
- FAP: The Next Billion Dollar Nuclear Theranostics Target?
- (2020) Jeremie Calais JOURNAL OF NUCLEAR MEDICINE
- OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models
- (2020) Myriam Fabre et al. CLINICAL CANCER RESEARCH
- Design and development of 99mTc labeled FAPI-tracers for SPECT-imaging and 188Re therapy.
- (2020) Thomas Lindner et al. JOURNAL OF NUCLEAR MEDICINE
- Clinical Results of Fibroblast Activation Protein (FAP) Specific PET and Implications for Radiotherapy Planning: Systematic Review
- (2020) Paul Windisch et al. Cancers
- Biodistribution, pharmacokinetics, dosimetry of [68Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [18F]F-FDG PET/CT in patients with various cancers
- (2020) Sanjana Ballal et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Development of novel FAP-targeted radiotracers with improved tumor retention
- (2019) Anastasia Loktev et al. JOURNAL OF NUCLEAR MEDICINE
- FAPI-PET/CT: Mean intensity of tracer-uptake (SUV) in 28 different kinds of cancer
- (2019) Clemens Kratochwil et al. JOURNAL OF NUCLEAR MEDICINE
- Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
- (2019) Thomas Powles et al. NATURE MEDICINE
- Development of quinoline based theranostic ligands for the targeting of fibroblast activation protein
- (2018) Thomas Lindner et al. JOURNAL OF NUCLEAR MEDICINE
- A new method for tumor imaging by targeting cancer associated fibroblasts
- (2018) Anastasia Loktev et al. JOURNAL OF NUCLEAR MEDICINE
- Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics
- (2018) Ellen Puré et al. ONCOGENE
- The Future of Radioligand Therapy: α, β, or Both?
- (2017) Uwe Haberkorn et al. JOURNAL OF NUCLEAR MEDICINE
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selective Homogeneous Assay for Circulating Endopeptidase Fibroblast Activation Protein (FAP)
- (2017) Travis W. Bainbridge et al. Scientific Reports
- RG7386, a Novel Tetravalent FAP-DR5 Antibody, Effectively Triggers FAP-Dependent, Avidity-Driven DR5 Hyperclustering and Tumor Cell Apoptosis
- (2016) P. Bru nker et al. MOLECULAR CANCER THERAPEUTICS
- Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells
- (2015) A. Lo et al. CANCER RESEARCH
- The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis
- (2015) Yannick Waumans et al. Frontiers in Immunology
- Extended Structure–Activity Relationship and Pharmacokinetic Investigation of (4-Quinolinoyl)glycyl-2-cyanopyrrolidine Inhibitors of Fibroblast Activation Protein (FAP)
- (2014) Koen Jansen et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity
- (2013) L.-C. S. Wang et al. Cancer Immunology Research
- Radioimmunotherapy of Fibroblast Activation Protein Positive Tumors by Rapidly Internalizing Antibodies
- (2012) E. Fischer et al. CLINICAL CANCER RESEARCH
- Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein-
- (2010) M. Kraman et al. SCIENCE
- Effective Immunoconjugate Therapy in Cancer Models Targeting a Serine Protease of Tumor Fibroblasts
- (2008) E. Ostermann et al. CLINICAL CANCER RESEARCH
- Cross-fire doses from β-emitting radionuclides in targeted radiotherapy. A theoretical study based on experimentally measured tumor characteristics
- (2008) S A Enger et al. PHYSICS IN MEDICINE AND BIOLOGY
- Fibroblast activation protein and chronic liver disease
- (2007) Xin Maggie Wang Frontiers in Bioscience-Landmark
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started